An Assessment of an HIV Prevention Intervention (Project AIM) Among Junior Secondary School Students in Eastern Botswana
NCT ID: NCT02455583
Last Updated: 2018-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4732 participants
INTERVENTIONAL
2014-08-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS
NCT00164385
Effect of HIV/STD Risk Reduction Program on South African Adolescents
NCT00559403
Brief HIV Prevention Counseling for STI Patients in South Africa
NCT01242501
A School-Based HIV/STD Prevention Program to Reduce Risky Sexual Behaviors Among Adolescents in Liberia
NCT00698321
Project TEAM: Teaching HIV Prevention in the HIV Clinic
NCT00164320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this 50 site, stratified, cluster, randomized control trial is to examine the efficacy of Project AIM to delay onset of sexual activity and reduce sexual risk behaviors among students (approximate ages 12- 17 years) in junior secondary schools (JSS) in Eastern Botswana.The study will involve enrolling a longitudinal cohort consisting of Form 1 students who will be randomized to either the intervention (Project AIM) or control condition and followed from the start of the Form 1 year to the end of the Form 3 year.
Outcomes will be assessed through participant self-report of sexual risk behavior and HSV-2 testing as a biomarker of self-reported sexual activity. Participants will complete a behavioral survey three times (baseline, 12 months, and 24 months) and HSV-2 testing two times (baseline and 24 months).
Effective implementation of Project AIM as part of the school health curriculum in Botswana would provide an evidence-based, in-school program option to aid and inform HIV prevention efforts for young adolescents across southern Africa. Implementation of the program will also build on existing programmatic efforts and infrastructure and attempt to demonstrate how the addition of an evidence-based, multi-component HIV prevention program will strengthen current youth HIV prevention policies and programming. In addition, rates of herpes simplex virus type 2 (HSV-2) from the study will provide the region with sexual risk behavior data and HSV-2 prevalence estimates for young adolescents in Eastern Botswana, which can inform public health recommendations as well as national policies for sexual/reproductive health and education among this population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care
All Form 1 learners at 25 of the 50 schools will receive HIV prevention sessions from the Botswana life skills education program for junior secondary school students called LIVING.
No interventions assigned to this group
Intervention
Form 1 learners at the 25 intervention schools will receive the Project AIM intervention and LIVING (standard of care).
Project AIM (Adult Identity Mentoring)
Project AIM consists of 14 sessions that are delivered twice a week. Each session is 40 minutes long.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Project AIM (Adult Identity Mentoring)
Project AIM consists of 14 sessions that are delivered twice a week. Each session is 40 minutes long.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent and literate in English or Setswana
* Able and willing to provide written informed assent (age 17 or under) or informed consent (age 18 and over)
* Parent/guardian provides permission (if age 17 or under) for child to participate
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Education and Skills Development, Botswana
UNKNOWN
Education Development Center, Inc.
INDUSTRY
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kim S Miller, PhD
Role: PRINCIPAL_INVESTIGATOR
Centers for Disease Control and Prevention
Nontobeko S Tau
Role: PRINCIPAL_INVESTIGATOR
Botswana: Minsitry of Education and Skills Development
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
50 Junior Secondary schools
Multiple Locations, Eastern Botswana, Botswana
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Clark LF, Miller KS, Nagy SS, Avery J, Roth DL, Liddon N, Mukherjee S. Adult identity mentoring: reducing sexual risk for African-American seventh grade students. J Adolesc Health. 2005 Oct;37(4):337. doi: 10.1016/j.jadohealth.2004.09.024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6451
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.